Just to add a bit to Uwe’s excellent explanation: Large injection volume is not just a large volume. Things can get worse if the sample solvent temporary disturbs/changes the pH of the eluent (when important and it typically is important in protein context) or f. ex. dilutes the eluent in terms of salt concentration (again very important factor in protein context). And then more exotic effects could be temperature disturbance (if the protein solution is very cold), too long injection process etc.
Best Regards
This is a good point.
I am purifying natural ligands. This means 6-8 HPLC steps. I typically run CH3CN + 0.1% TFA in the mobile phase for all HPLC steps (I have used 1-propanol, but always stick with the TFA or HFBA as ion-pairing agent).
Instead of drying down the fractions from the previous run, I just dilute them with 2-3 volumes 0.1% TFA and re-inject. This makes for large injection volumes that still contain 5-10% CH3CN
This is too low organic % to elute my ligand, however, perhaps it is enough to spread the band down the column while I am injecting the rest..?
The reason I don't dry the fractions before proceeding to the next step is fear of losing some precious purified ligand to irreversible binding to the PP tube upon drying.
I'm gong to add 100 micrograms of inert protein, such as BSA, to my tubes and dry them down. Hopefully when I bring the residue back up in a small volume of starting mobile phase solvent, the smaller inj volume will yield more narrow area of activity.
Here is an example of what I'm referring to. The is a C4 4.6 mm ID column with CH3CN + 0.1% HFBA in the mobile phase.
Gradient:
5-30% CH3CN over 5 min
30-50% CH3CN over 60 min
1.5 minute fractions collected